A new biotech licensing Chinese drugs with a unique approach gets high-profile backing
Expedition Therapeutics, a new startup hoping to source the best therapies being developed in China and bring them stateside, has secured high-profile backing.
Tweets with this article
Matthew Herper
Expedition Therapeutics, with high-profile backing, seeks to license Chinese drugs #statbreakthrough https://t.co/ByxzBu90Qv
Related Articles
STAT readers on cadavers in med education, doctors and AI, and more
“Unless cadavers can be preserved to look fresh instead of semi-mummified, I don’t see any advantage of continuing their use in the face of technology,”…
FDA tells drugmakers to redo studies run by a contract research firm due to data integrity issues
Citing “objectionable conditions,” the agency said there were problems with the way Raptim Research tested medicines in India.
Federal judge issues permanent injunction on Trump cuts to research overhead payments
A ruling on Friday sets up the next chapter of the legal battle between the Trump administration and stakeholders in academic research.
FDA tells drugmakers to redo studies run by a contract research firm due to data integrity issues
Citing “objectionable conditions,” the agency said there were problems with the way Raptim Research tested medicines in India.
Trump administration declines to expand Medicare coverage for obesity drugs
The Trump administration has chosen not to finalize a rule proposed by the Biden administration that would have allowed Medicare to cover blockbuster weight loss…
Trump administration declines to expand Medicare coverage for obesity drugs
The Trump administration has chosen not to finalize a rule proposed by the Biden administration that would have allowed Medicare to cover blockbuster weight loss…
FDA tells drugmakers to redo studies run by a contract research firm due to data integrity issues
Citing “objectionable conditions,” the agency said there were problems with the way Raptim Research tested medicines in India.
FDA tells drugmakers to redo studies run by a contract research firm due to data integrity issues
Citing “objectionable conditions,” the agency said there were problems with the way Raptim Research tested medicines in India.
Up and down the ladder: The latest comings and goings
From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.
CDC division responsible for asthma control and lead poisoning prevention effectively eliminated
The CDC division responsible for asthma control and lead poisoning prevention has been effectively eliminated as part of the layoffs at HHS.